Alaunos Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Alaunos Therapeutics, Inc. reported Earnings Per Share Diluted of $2.20 (loss) per share for the year ending 2025.

  • Alaunos Therapeutics, Inc. showed an increase of +24.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Alaunos Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2009: $0.13 (loss) per share | Q3 2010: $0.26 (loss) per share | Q3 2011: $0.01 (loss) per share | Q3 2012: $0.23 (loss) per share | Q1 2018: $0.15 (loss) per share | Q2 2018: $0.12 (loss) per share | Q3 2018: $0.13 (loss) per share | Q4 2018: $1.29 per share | Q1 2019: $0.08 (loss) per share | Q2 2019: $0.09 (loss) per share | Q3 2019: $0.43 (loss) per share | Q4 2019: $0.09 (loss) per share | Q1 2020: $0.09 (loss) per share | Q2 2020: $0.09 (loss) per share | Q3 2020: $0.10 (loss) per share | Q4 2020: $0.11 (loss) per share | Q2 2021: $0.11 (loss) per share | Q3 2021: $0.11 (loss) per share | Q1 2022: $0.05 (loss) per share | Q2 2022: $0.05 (loss) per share | Q3 2022: $0.04 (loss) per share | Q1 2023: $0.63 (loss) per share | Q2 2023: $5.49 (loss) per share | Q3 2023: $5.30 (loss) per share | Q1 2024: $1.05 (loss) per share | Q2 2024: $0.71 (loss) per share | Q3 2024: $0.70 (loss) per share | Q1 2025: $0.67 (loss) per share | Q2 2025: $0.63 (loss) per share | Q3 2025: $0.55 (loss) per share.
  • Over the full 10 years of available data (2016 to 2025), Alaunos Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 66.7%.
  • Historical annual values: Fiscal year 2025: $2.20 (loss) per share | Fiscal year 2024: $2.92 (loss) per share | Fiscal year 2023: $21.97 (loss) per share | Fiscal year 2022: $2.61 (loss) per share | Fiscal year 2021: $0.37 (loss) per share | Fiscal year 2020: $0.38 (loss) per share | Fiscal year 2019: $0.70 (loss) per share | Fiscal year 2018: $0.96 per share | Fiscal year 2017: $0.53 (loss) per share | Fiscal year 2016: $1.32 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: